Treatment of UTI in Men with Foley Catheters
For symptomatic catheter-associated UTI in men, replace the catheter and treat with 7-14 days of antibiotics (14 days if prostatitis cannot be excluded), using empiric therapy with either amoxicillin plus an aminoglycoside, a second-generation cephalosporin plus an aminoglycoside, or an IV third-generation cephalosporin for systemic symptoms 1.
Critical First Step: Distinguish Symptomatic from Asymptomatic Bacteriuria
The most important clinical decision is determining whether the patient has true catheter-associated UTI (CAUTI) versus catheter-associated asymptomatic bacteriuria (CA-ABU):
- Do NOT treat asymptomatic bacteriuria - approximately 32% of asymptomatic cases are inappropriately treated with antibiotics 2, and treatment confers no clinical benefit 2, 3
- Only treat symptomatic infection with fever, rigors, altered mental status, flank pain, costovertebral angle tenderness, acute hematuria, pelvic discomfort, or new dysuria 1
Common pitfall: Pyuria and positive urine cultures are universal in catheterized patients and do NOT indicate need for treatment without symptoms 4, 5.
Management Algorithm
Step 1: Confirm Symptomatic Infection
Look for:
- New or worsening fever/rigors
- Altered mental status, malaise, or lethargy (with no other identified cause)
- Flank pain or costovertebral angle tenderness
- Acute hematuria or pelvic discomfort
- Dysuria or suprapubic pain (especially if catheter recently removed) 1
Step 2: Obtain Urine Culture BEFORE Starting Antibiotics
- Replace the catheter if it has been in place ≥2 weeks, then collect urine through the new catheter 5
- This provides bladder urine without biofilm contamination and improves clinical outcomes 5
Step 3: Initiate Empiric Antibiotic Therapy
For patients with systemic symptoms (the EAU 2024 guideline provides strong recommendations) 1:
Preferred empiric regimens:
- Amoxicillin PLUS an aminoglycoside, OR
- Second-generation cephalosporin PLUS an aminoglycoside, OR
- IV third-generation cephalosporin
Fluoroquinolone considerations (ciprofloxacin):
- Only use if local resistance <10% AND patient doesn't require hospitalization OR has β-lactam anaphylaxis 1
- Do NOT use if patient is from urology department or used fluoroquinolones in last 6 months 1
Step 4: Treatment Duration
Men require longer treatment than women because prostatitis cannot be reliably excluded 1, 6:
- 14 days when prostatitis cannot be excluded (standard for men) 1
- 7 days may be considered if patient is hemodynamically stable, afebrile for ≥48 hours, and there are contraindications to longer antibiotic course 1
- Recent IDSA 2025 guidelines support 5-7 days for fluoroquinolones or 7 days for non-fluoroquinolones in improving patients, but note men with febrile UTI where prostatitis is suspected benefit from 10-14 days 6
Step 5: Tailor Therapy Based on Culture Results
- Switch to targeted narrow-spectrum oral therapy once susceptibilities return 1, 7
- The microbial spectrum includes E. coli, Proteus, Klebsiella, Pseudomonas, Serratia, and Enterococcus with increasing multidrug resistance 1, 4
Key Nuances in the Evidence
The 2024 EAU guidelines 1 provide the most authoritative framework, emphasizing combination therapy for complicated UTI with systemic symptoms. The 2025 IDSA guidelines 6, 7 support shorter durations but acknowledge men with suspected prostatitis need longer courses. The convergence of evidence strongly supports catheter replacement when feasible 5 and avoiding treatment of asymptomatic bacteriuria 2, 3.
Duration of catheterization is the single most important risk factor for developing CAUTI 1, 3, with bacteriuria occurring at 3-8% per day 1. Biofilm formation on catheters facilitates persistent colonization and reduces antimicrobial susceptibility 4.